More articles from MTA I: Sarcoma/Melanoma Posters

You have access
Inter-reader reliability and variability of 18F-FDG PET volumetric tumor parameters in sarcoma
Uzma Rana, Srinivasan Senthamizhchelvan, Richard Wahl and Rathan Subramaniam

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1614;
You have access
Correlation of metabolic activity on FDG PET/CT to the size of benign and malignant lesions in patients with neurofibromatosis type 1 (NF1)
Alin Chirindel, Muhammad Chaudhry, Jaishri Blakeley and Richard Wahl

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1618;
You have access
Comparison of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and (99m)Tc-methylene diphosphonate bone scintigraphy for detection of bone metastasis in osteosarcoma
Chang-Bae Kong, Byung Byun Byun and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1613;
You have access
Not all progressive metabolic diseases on PET are equal in patients with relapsed or refractory sarcoma
Joo Hyun Oo, Laurence Baker and Richard Wahl

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1617;
You have access
Comparison of key sentinel node biopsy parameters for 99mTc-tilmanocept and 99mTc-sulfur colloid in melanoma
Vernon Sondak, Jonathan Zager, Christopher Puleo, Julian Kim and Stanley Leong

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1616;
You have access
The value of 18F FDG PET/CT in the evaluation of soft tissue sarcomas
Camila Mosci, Kristen Ganjoo, Jeffrey Norton, Erik Mittra, Andrew Quon and Andrei Iagaru

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1612;
You have access
FDG-PET/CT for staging in bone sarcomas: Comparison with bone scintigraphy and chest CT
Jean Louis Alberini, Mathieu Gauthé, Myriam Wartski, Nina Jehanno, Laurence Champion and Veronique Edeline

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1609;
You have access
Can BRAF V600E mutation alter F-18 FDG uptake?
Lindsay Luttrell, Yong Bradley, Laurentia Nodit, Karla Matteson and James Lewis

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1615;
You have access
Prognostic value of SUVmax measured by F-18 FDG PET/CT in patients with malignant melanoma
Jae Pil Hwang, Ilhan Lim, Kyung Jin Rhim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1611;
You have access
The role of F18-FDG PET/CT as a prognostic factor in patients with synovial sarcoma
Kyoung Jin Chang, Ilhan Lim, Jae-Pil Hwang, Joon Yeun Park, Byung il Kim, Chang Woon Choi and Sang Moo Lim

Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1435;

Main menu

User menu

Search

More articles from MTA I: Sarcoma/Melanoma Posters

Pages